Twinbeech Capital LP Spring Works Therapeutics, Inc. Transaction History
Twinbeech Capital LP
- $4.99 Billion
- Q3 2024
A detailed history of Twinbeech Capital LP transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Twinbeech Capital LP holds 138,234 shares of SWTX stock, worth $5.02 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
138,234
Previous 87,058
58.78%
Holding current value
$5.02 Million
Previous $3.28 Million
35.07%
% of portfolio
0.09%
Previous 0.07%
Shares
8 transactions
Others Institutions Holding SWTX
# of Institutions
237Shares Held
68.9MCall Options Held
144KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA6.71MShares$244 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$204 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.84MShares$140 Million4.54% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.52MShares$128 Million0.01% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$124 Million5.82% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.27B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...